Revision history of "Postmarketing Surveillance"

From DrugPedia: A Wikipedia for Drug discovery

Jump to: navigation, search
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)

Diff selection: mark the radio boxes of the versions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with current version, (last) = difference with preceding version, M = minor edit.

  • (cur) (last) 06:44, 11 August 2008 Jasjit (Talk | contribs) (509 bytes) (New page: '''Postmarketing Surveillance''' is a risk assessment program to identify adverse effects of drug after its approval. FDA maintains a system of postmarketing surveillance and risk assessm...)
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)